San Diego-based mostly Viking Therapeutics marked by itself as a serious competitor while in the weight loss drug industry in February right after revealing promising details from the mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given being a weekly injection As well as in March